In conclusion, although BSCB restoration, driven by Gi signaling in astrocytes at early stages of the disease, was not associated with any effect on disease markers, it could be linked to neuroprotective effects at later phases of ALS pathology. The gene discussed is GNAI1; the disease is amyotrophic lateral sclerosis.